Laxmi Bhatt

Laxmi Bhatt has focused on the complex intersection of hormone-sensitive cancers and fertility preservation, developing protocols for safe ovarian stimulation in estrogen receptor-positive breast cancer patients using letrozole-based regimens that minimize hormonal exposure. Her research on the reproductive impact of extended endocrine therapy has quantified the age-dependent fertility decline during tamoxifen and aromatase inhibitor treatment. Her work on pregnancy safety after breast cancer has provided reassuring evidence that supports the POSITIVE trial findings enabling treatment interruption for conception.